002603 以岭药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.62012.08523.62614.94114.450
总资产报酬率 ROA (%)1.7828.11816.15811.01611.854
投入资产回报率 ROIC (%)2.1409.83219.72213.30312.087

边际利润分析
销售毛利率 (%)51.47757.28263.77163.61564.493
营业利润率 (%)15.51517.24922.57715.51016.374
息税前利润/营业总收入 (%)14.94016.57822.34615.52916.176
净利润/营业总收入 (%)11.96813.02818.81313.26113.834

收益指标分析
经营活动净收益/利润总额(%)97.51694.947103.068100.217101.204
价值变动净收益/利润总额(%)4.5513.8770.414-1.4092.081
营业外收支净额/利润总额(%)-6.226-5.677-1.759-0.988-1.094

偿债能力分析
流动比率 (X)1.5531.4721.4961.8922.438
速动比率 (X)1.0860.9191.0791.3271.733
资产负债率 (%)31.46032.63633.11129.69922.354
带息债务/全部投入资本 (%)14.84614.73316.3569.743--
股东权益/带息债务 (%)549.997554.734495.085889.9091,802.472
股东权益/负债合计 (%)218.120206.624202.053236.627347.190
利息保障倍数 (X)44.67864.873140.59390.712-773.474

营运能力分析
应收账款周转天数 (天)88.55872.01247.93448.8120.000
存货周转天数 (天)163.944182.969146.462159.0760.000